期刊文献+

艾沙拉唑的合成和分子力场模拟研究

Study on the Synthesis Properties of Esaprazole
下载PDF
导出
摘要 研究了艾沙拉唑(Ⅱ)的合成和分子力场。以环己胺和氯乙酰氯为原料合成了N-环己基-2-氯乙酰胺(Ⅰ)。再以Ⅰ与哌嗪为原料合成了Ⅱ。采用三因素三水平的正交法对Ⅰ的合成条件进行了优化,发现合成Ⅰ的最优条件为:n环己胺∶n氯乙酰氯∶nNaOH=1∶1.5∶3,反应温度为15℃;最优条件下平行实验的RSD=0.42%。采用重结晶法进行了Ⅱ的纯化,与已有文献相比,易于工业化。利用软件FieldTemplatre2.2.0和FieldAlign2.1进行了Ⅱ的分子力场计算,发现其与苯并咪唑类质子泵抑制剂与靶体作用的分子力场接近,显示出Ⅱ具有质子泵抑制活性的潜力。 N-cyclohexyl-2-chloroacetamide was prepared from cyclohexylamine and chloroacetylchloride. Esaprazole is prepared from N-cyclohexyl-2-claloroacetamide and piperazine. They are characterized by IR spectra and 1H-NMR spectra. The orthogonal optimization method of three factors and three levels is designed and used to optimize the synthesis route of N-cyclohexyl-2-chloroacetamide. It is found that the optimal materials mol-ratio : n cyclohexylamine : n chloroacetylchloride : nNaOH=1 : 1. 5 : 3, and the optimal temperature is at 15℃. Under the optimal conditions, N-cyclohexyl-2-chloroacetamide is prepared three times with the high average yield 93% and the RSD=0. 42%, which prove that the synthesis route is stable. Esaprazole is purified by re-crystallization method, which is much easy to industry than the literature method vacuum distillation. The molecular force field of omeprazole, pantoprazole and rabeprazole is counted by FieldTemplater2.2.0, which is used as a model to count the molecular force field of esaprazole by FieldAlign2. 1.1. It is found that it is similar between the molecular force field of esaprazole and benzimidazoles, which shows that the bio-activities of esaprazole and benzimidazoles is similar.
出处 《浙江理工大学学报(自然科学版)》 2012年第1期146-149,共4页 Journal of Zhejiang Sci-Tech University(Natural Sciences)
基金 国家自然科学基金项目(20901067) 浙江省自然科学基金项目(Y4080342)
关键词 艾沙拉唑 合成 表征 正交优化 分子力场 esaprazole synthesis characterization orthogonal optimization design molecular force field
  • 相关文献

参考文献11

  • 1郭伦锋,郭庆东,王四旺.胃溃疡治疗药物的研究进展[J].亚太传统医药,2008,4(8):78-80. 被引量:42
  • 2许良中.胃癌的元凶——幽门螺杆菌[J].抗癌,2005(2):16-17. 被引量:1
  • 3Corvi-Mora, Camillo. N-Cyclohexyl-piperazineacetamides: 德国,DE2702537[P].1977-07-28.
  • 4Corvi-Mora, Camillo. Piperazine derivatives and their homologs:美国,US4278796[P].1981-07-14.
  • 5Meisel, Gerard M, Ciociola, Arthur A. Gasl:rointestinal compositions for treating or preventing gasl:rointestinal disorders:美国,US20040013741[P].2004-01-22.
  • 6杨继红,王培民,周力,张贵平,赵亚萍.质子泵抑制剂研究进展[J].中国药房,2000,11(4):184-185. 被引量:10
  • 7Corvi-Mora, Camillo. Organometal complexes of N-cy- clohexyl piperazinoacetamides or-propionamides and their use as ulcer- and secretion-preventation and buffe-ring agents:德国,DE3310584[P].1983-10-13.
  • 8Kokai Tokkyo Koho. 1-(2, 3, 4-Trimethoxycinnamoyl )-4- aminocarbonyl alkylpiperazine and homopiperazine deriva-tives:日本,JP58216170[P].1983-12-15.
  • 9Del Soldato, Piero. Synthesis, activity and formulations of pharmaceutical compounds for treatment of oxidative stress and/or endothelial dysfunction:国际,W02001012584[P].2001-02-22.
  • 10Blandizzi C, Natale G, De Bona M, et al. Gastric anti- secretory effects of esaprazole in rats[J]. Digestion, 1992, 51(4): 226-232.

二级参考文献21

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部